CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (DEFICIENCY) (Unaudited) - USD ($)	Preferred Stock	Common Stock	Additional Paid-In Capital	Common Stock Subscription Receivable From Related Party	Accumulated Deficit	Series B Preferred Stock	Total
Beginning Balance at Jul. 31, 2020	$ 202	$ 9,669	$ 1,456,644	$ (550,000)	$ (1,066,928)	$ 72	$ (150,341)
Beginning Balance (in shares) at Jul. 31, 2020	1,434	96,691,761				1,347
Payments received on common stock subscription receivable from related party				67,400			67,400
Conversion of unsecured convertible promissory note payable		$ 13	25,669				25,682
Conversion of unsecured convertible promissory note payable (in share)		128,410
Sales of common stock		$ 1,320	658,680				660,000
Sales of common stock (in share)		13,200,000
Stock-based compensation expense			22,239				22,239
Net loss					(477,730)		(477,730)
Ending Balance at Oct. 31, 2020	$ 202	$ 11,002	2,163,232	(482,600)	(1,544,658)	$ 72	147,250
Ending Balance (in shares) at Oct. 31, 2020	1,434	110,020,171				1,347
Beginning Balance at Jul. 31, 2020	$ 202	$ 9,669	1,456,644	(550,000)	(1,066,928)	$ 72	(150,341)
Beginning Balance (in shares) at Jul. 31, 2020	1,434	96,691,761				1,347
Stock-based compensation expense							44,478
Net loss							(1,000,403)
Ending Balance at Jan. 31, 2021	$ 202	$ 12,127	3,357,356	(482,600)	(2,063,901)	$ 72	819,826
Ending Balance (in shares) at Jan. 31, 2021	1,434	121,270,171				1,347
Beginning Balance at Oct. 31, 2020	$ 202	$ 11,002	2,163,232	(482,600)	(1,544,658)	$ 72	147,250
Beginning Balance (in shares) at Oct. 31, 2020	1,434	110,020,171				1,347
Sales of common stock		$ 1,125	1,123,875				1,125,000
Sales of common stock (in share)		11,250,000
Stock-based compensation expense			22,239				22,239
Net loss					(519,243)		(522,673)
Ending Balance at Jan. 31, 2021	$ 202	$ 12,127	$ 3,357,356	$ (482,600)	$ (2,063,901)	$ 72	$ 819,826
Ending Balance (in shares) at Jan. 31, 2021	1,434	121,270,171				1,347